Published in Gastroenterology on April 01, 1992
Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci (2012) 2.08
Hepatitis C: progress and problems. Clin Microbiol Rev (1994) 1.37
Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.15
Autoimmune hepatitis and its variant syndromes. Gut (2001) 1.00
Autoantibodies in chronic hepatitis C: A clinical perspective. World J Hepatol (2015) 0.96
Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment. World J Gastroenterol (2007) 0.95
Alanine aminotransferase elevation during peginterferon alpha-2a or alpha-2b plus ribavirin treatment. Int J Med Sci (2013) 0.88
A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome. Gastroenterol Hepatol (N Y) (2010) 0.84
Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis. Clin J Gastroenterol (2012) 0.83
Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Dig Dis Sci (2015) 0.77
Hepatitis C and kidney transplantation. Int J Nephrol (2011) 0.77
Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact? Gut (1994) 0.76
Chronic hepatitis C and autoimmunity: good response to immunosuppressive treatment. Dig Dis Sci (1997) 0.76
Treatment of hepatitis C virus infection and associated vascular complications: a literature review. Iran J Med Sci (2014) 0.75
Extremely acute exacerbation of interstitial pneumonia after interferon-alpha treatment for metastatic renal cell carcinoma. Int J Clin Oncol (2009) 0.75
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89
Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med (1991) 6.09
Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med (1995) 5.98
Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med (2000) 5.27
Antibody to hepatitis-B-virus core in man. Lancet (1973) 4.24
Management of hepatitis B: 2000--summary of a workshop. Gastroenterology (2001) 4.17
On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med (1975) 4.11
Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med (1989) 3.45
Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med (1990) 2.99
NIH conference. Hepatocellular carcinoma. Ann Intern Med (1988) 2.94
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med (1986) 2.85
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med (1995) 2.61
Long-term therapy of chronic hepatitis B with lamivudine. Hepatology (2000) 2.49
Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 2.49
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Spontaneous bacterial peritonitis caused by infection with Listeria monocytogenes: a case report and review of the literature. Am J Gastroenterol (1998) 2.35
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol (1995) 2.34
Genotypic analysis of hepatitis C virus in American patients. Hepatology (1994) 2.33
Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med (1978) 2.30
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology (1991) 2.25
Measurements of iron status in patients with chronic hepatitis. Gastroenterology (1992) 2.22
Long-term therapy of chronic delta hepatitis with peginterferon alfa. Aliment Pharmacol Ther (2014) 2.19
Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Hepatology (1991) 2.15
Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest (1996) 2.04
Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology (1992) 1.99
Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication. N Engl J Med (1974) 1.98
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med (1981) 1.96
Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology (1987) 1.94
Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol (2000) 1.92
Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med (1991) 1.92
Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen. N Engl J Med (1974) 1.92
Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology (1988) 1.91
Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology (1991) 1.82
Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet (1978) 1.82
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment Pharmacol Ther (2012) 1.81
Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology (1996) 1.78
Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest (1991) 1.77
Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med (1982) 1.67
A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med (1987) 1.61
Toward universal vaccination against hepatitis B virus. N Engl J Med (1989) 1.60
Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology (1999) 1.59
Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology (1999) 1.58
Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology (1991) 1.57
Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis (1975) 1.55
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2008) 1.54
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology (1997) 1.54
Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest (1983) 1.52
Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin Infect Dis (1998) 1.51
Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. J Infect Dis (1976) 1.51
Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology (1995) 1.51
Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol (2000) 1.50
Drug-induced liver injury: mechanisms and test systems. Hepatology (2001) 1.49
Hepatitis C in asymptomatic blood donors. Hepatology (1997) 1.48
Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology (1987) 1.45
The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology (1991) 1.45
10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology (1998) 1.44
Lamivudine for chronic delta hepatitis. Hepatology (1999) 1.44
Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer (1989) 1.43
Viral hepatitis and hepatocellular carcinoma. Gastroenterol Clin North Am (1994) 1.42
Therapy of hepatitis C. Semin Liver Dis (1995) 1.42
Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene (2006) 1.41
Methotrexate therapy of primary biliary cirrhosis: promising but worrisome. Gastroenterology (1991) 1.41
Viral hepatitis, type B, in experimental animals. Am J Med Sci (1976) 1.41
Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis. Am J Gastroenterol (1990) 1.41
Seizures during alpha interferon therapy. J Hepatol (1996) 1.39
Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology (1984) 1.38
Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med (1991) 1.36
Side effects of alpha interferon. Semin Liver Dis (1989) 1.35
NIH conference: Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med (1983) 1.35
Increased waiting time for liver transplantation results in higher mortality. Transplantation (1997) 1.34
Subtyping of hepatitis B surface antigen and antibody by radioimmunoassay. Gastroenterology (1977) 1.34
Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology (1989) 1.33
Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med (1987) 1.33
Hepatitis C in African Americans: summary of a workshop. Gastroenterology (2000) 1.32
Immunology and the liver. Hepatology (1991) 1.31
Hepatitis B core antigen: immunology and electron microscopy. J Virol (1974) 1.30
A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology (1992) 1.30
Complementary and alternative medicine in chronic liver disease. Hepatology (2001) 1.29
Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat (1995) 1.28
Serologic markers of hepatitis B virus infection. Annu Rev Med (1981) 1.28
Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology (1997) 1.28
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon. Hepatology (1992) 1.26
Transmission of non-A, non-B hepatitis. Ann Intern Med (1977) 1.25